Compile Data Set for Download or QSAR
maximum 50k data
Found 11 Enz. Inhib. hit(s) with all data for entry = 6520
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135848(US8853206, 54)
Affinity DataIC50:  85nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135846(US8853206, 46)
Affinity DataIC50:  114nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135844(US8853206, 35)
Affinity DataIC50:  132nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135843(US8853206, 29)
Affinity DataIC50:  136nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135842(US8853206, 27)
Affinity DataIC50:  152nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135845(US8853206, 40)
Affinity DataIC50:  601nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135851(US8853206, 76)
Affinity DataIC50:  1.40E+3nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135850(US8853206, 72)
Affinity DataIC50:  1.70E+3nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135849(US8853206, 60)
Affinity DataIC50:  2.10E+3nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135852(US8853206, 82)
Affinity DataIC50:  8.40E+3nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM135847(US8853206, 47)
Affinity DataIC50:  1.00E+4nMpH: 7.5Assay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In DepthDetails US Patent